mda-mb-231 cells

Explore academic connections and research related to this keyword

263
Views
7
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Combined Magnetoliposome Formation and Drug Loading in One Step for Efficient Alternating Current-Magnetic Field Remote-Controlled Drug Release.
Fortes Brollo, Maria Eugenia;Domínguez-Bajo, Ana;Tabero, Andrea;Domínguez-Arca, Vicente;Gisbert, Vic...
2020 ACS applied materials & interfaces DOI: 10.1021/acsami.9b206... 279 views
2
Biocompatibility assessment of sub-5 nm silica-coated superparamagnetic iron oxide nanoparticles in human stem cells and in mice for potential application in nanomedicine.
Ledda, Mario;Fioretti, Daniela;Lolli, Maria Grazia;Papi, Massimiliano;Di Gioia, Cira;Carletti, Raffa...
2020 Nanoscale DOI: 10.1039/c9nr09683c 271 views
3
The Fluoro-Thiazolylhydrazone Compound TSC-3C Inhibits Triple Negative Breast Cancer (TNBC) Cell Line Activity by Promoting Apoptosis, Regulating the MAPK Pathway and Inducing Mitochondrial Dysfunction.
Zhang, Jiajia;Dai, Jiajia;Zheng, Qingxuan;Guo, Shuju;Yu, Yanyan;Hu, Wenpeng;Gao, Yanan;Shi, Dayong;
2020 International journal of molecular sciences DOI: E1038 503 views
4
polysaccharide from sepia esculenta ink and cisplatin inhibit synergistically proliferation and metastasis of triple-negative breast cancer mda-mb-231 cells
;Hua-Zhong Liu;Wei Xiao;Yi-Peng Gu;Ye-Xing Tao;Da-Yan Zhang;Hui Du;Jiang-Hua Shang
2016 PloS one DOI: 10.22038/ijbms.2016.... 222 views

Related Journals

ACS applied materials & interfaces
ISSN: 1944-8244 1,540 views
Nanoscale
ISSN: 2040-3372 801 views
International journal of molecular sciences
ISSN: 1422-0067 1,082 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

doxorubicin magnetic hyperthermia magnetoliposomes hela cells drug delivery carrier superparamagnetic iron oxide nanoparticle apoptosis mapk pathway fluoro-thiazolylhydrazone phosphorylated c-jun n-terminal kinase (p-jnk) phosphorylated p44/42 mapk (erk1/2) triple negative breast cancer cisplatin